The promising results of combining GHRA with chemotherapy observed here, not only indicates an improved tumor clearance, but also an opportunity to investigate the lowering of chemotherapy dosages and minimizing the associated side-effects in thousands of cancer patients with GH-responsive tumors. Here, GH1 is linked to cancer.